Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mrus, J. M.
Right arrow Articles by Tsevat, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mrus, J. M.
Right arrow Articles by Tsevat, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Impact of Expected HIV Transmission Rates on the Effectiveness and Cost of Ruling Out HIV Infection in Infants

Joseph M. Mrus, MD, MSc

Section of Outcomes Research, Division of General Internal Medicine, Department of Internal Medicine, and Center for Clinical Effectiveness, Institute for Health Policy and Health Services Research, University of Cincinnati Medical Center, Cincinnati, OH and Department of Pediatrics, University of Cincinnati Medical Center, Cincinnati, OH joseph.mrus{at}uc.edu

Michael S. Yi, MD, MSc

Section of Outcomes Research, Division of General Internal Medicine, Department of Internal Medicine, and Center for Clinical Effectiveness, Institute for Health Policy and Health Services Research, University of Cincinnati Medical Center, Cincinnati, OH and Department of Pediatrics, University of Cincinnati Medical Center, Cincinnati, OH

Mark H. Eckman, MD, MSc

Section of Outcomes Research, Division of General Internal Medicine, Department of Internal Medicine, and Center for Clinical Effectiveness, Institute for Health Policy and Health Services Research, University of Cincinnati Medical Center, Cincinnati, OH

Joel Tsevat, MD, MPH

Section of Outcomes Research, Division of General Internal Medicine, Department of Internal Medicine, and Center for Clinical Effectiveness, Institute for Health Policy and Health Services Research, University of Cincinnati Medical Center, Cincinnati, OH

Objective. To quantify the costs and effectiveness of different strategies for ruling out HIV infection in infants born to HIV-infected mothers in the United States. Methods.The authors assessed 4 different testing strategies that incorporated serial HIV DNA polymerase chain reaction (PCR) testingwith or without enzyme-linked immunosorbent assay (ELISA) anti-body testing. Testing costs, false reassurance rates, and incremental cost-effectiveness ratios were compared for the 4 strategies. Results.In HIV-exposed infants, HIV DNA PCR testing at birth, 1 month, and 4 months of age results in a false reassurance rate of 21 per million (at a 2% transmission rate). Adding an ELISA test lowers the false reassurance rate to 0.052 per million at a cost of $570,000 per additional case detected; adding another PCR lowers the false reassurance rate to 1.49 per million at a cost of $720,000 per additional case detected compared with the 3-PCR strategy. At a high transmission rate (20%), there would be substantially more erroneously negative results (false reassurance rate is 256 per million with PCR testing at birth, 1 month, and 4 months) and consequently more favorable cost-effectiveness ratios with additional testing: $47,000 per additional case detected by adding1 ELISA test and $59,000 per additional case detected by adding another PCR test. Conclusions.False-negative HIV results after serial testingin exposed infants are rare, and the incremental cost-effectiveness ratios of additional tests are substantial at low transmission rates. However, the false reassurance rate increases considerably with a 3-PCR strategy and additional testing becomes more cost-effective at greater transmission rates; therefore, additional testingmay be warranted in infants at greater risk of infection.

Key Words: HIV • testing • vertical transmission • infants

Medical Decision Making, Vol. 22, No. 5 suppl, S38-S44 (2002)
DOI: 10.1177/027298902237710


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
D. K. Owens
Analytic Tools for Public Health Decision Making
Med Decis Making, October 1, 2002; 22(5_suppl): S3 - S10.
[PDF]